참고문헌
- Baek HM, Chen JH, Yu HJ, et al (2008). Detection of choline signal in human breast lesions with chemical-shift imaging. J Magnetic Resonance Imaging, 27, 1114-21. https://doi.org/10.1002/jmri.21309
- Baltzer PA, Dietzel M (2013). Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T-systematic review and meta-analysis. Radiol, 267, 735-46. https://doi.org/10.1148/radiol.13121856
- Barker PB, Bizzi A, De Stefano N, et al (2009). MRS in breast cancer. In 'Clinical MR spectroscopy: techniques and applications', Eds Cambridge University Press, 229-42
- Begley JK, Redpath TW, Bolan PJ, et al (2012). In vivo proton magnetic resonance spectroscopy of breast cancer: a review of the literature. Breast Cancer Res, 14, 207. https://doi.org/10.1186/bcr3132
- Bolan PJ, DelaBarre L, Baker EH, et al (2002). Eliminating spurious lipid sidebands in 1H MRS of breast lesions. Magn Reson Med, 48, 215-22. https://doi.org/10.1002/mrm.10224
- Bolan PJ, Henry PG, Baker EH, et al (2004). Measurement and correction of respiration-induced B0 variations in breast 1H MRS at 4 Tesla. Magn Reson Med, 52, 1239-45. https://doi.org/10.1002/mrm.20277
- Cecil KM, Schnall MD, Siegelman ES, et al (2001). The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treatm, 68, 45-54. https://doi.org/10.1023/A:1017911211090
- Fischer U (2004a). normal findings in MR mammography. In 'Practical MR mammography', Eds Thieme, 41-50
- Fischer U (2004b). technique and methods In 'Practical MR mammography', Eds Thieme, 11-21
- Hendrick RE (2008a). breast magnetic resonance imaging aquisition protocols. In 'Breast MRI: Fundamentals and Technical Aspects', Eds 69-135
- Hendrick RE (2008b). contrast agents in breast magnetic resonance imaging In 'Breast MRI: Fundamentals and Technical Aspects', Eds 113-34
- Huang W, Fisher PR, Dulaimy K, et al (2004). Detection of Breast Malignancy: Diagnostic MR Protocol for Improved Specificity 1. Radiol, 232, 585-91. https://doi.org/10.1148/radiol.2322030547
- Jacobs MA, Barker PB, Argani P, et al (2005). Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imag, 21, 23-8. https://doi.org/10.1002/jmri.20239
- Jafari M, Nakhaee N, Goudarzi R, et al (2014). Participation of the Women Covered by Family Physicians in Breast Cancer Screening Program in Kerman, Iran. Asian Pac J cancer prevention, 16, 4555-61.
- Katz-Brull R, Lavin PT, Lenkinski RE (2002). Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J National Cancer Inst, 94, 1197-203. https://doi.org/10.1093/jnci/94.16.1197
- Kousi E, Tsougos I, Vasiou K, et al (2012). Magnetic resonance spectroscopy of the breast at 3T: pre-and post-contrast evaluation for breast lesion characterization. Scientific world J, 2012.
- Kuhl CK, Mielcareck P, Klaschik S, et al (1999). Dynamic breast mr imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions? 1. Radiol, 211, 101-10. https://doi.org/10.1148/radiology.211.1.r99ap38101
- Kvistad KA, Bakken IJ, Gribbestad IS, et al (1999). Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy. J Magn Reson Imaging, 10, 159-64. https://doi.org/10.1002/(SICI)1522-2586(199908)10:2<159::AID-JMRI8>3.0.CO;2-0
- Mackinnon WB, Barry PA, Malycha PL, et al (1997). Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiol, 204, 661-6. https://doi.org/10.1148/radiology.204.3.9280241
- Melsaether A, Gudi A (2014). Breast Magnetic resonance imaging performance: safety, techniques, and updates on diffusion-weighted imaging and magnetic resonance spectroscopy. Topics Magn Reson Imaging, 23, 373-84. https://doi.org/10.1097/RMR.0000000000000035
- Menezes GL, Knuttel FM, Stehouwer BL, et al (2014). Magnetic resonance imaging in breast cancer: A literature review and future perspectives. World J Clinical Oncol, 5, 61. https://doi.org/10.5306/wjco.v5.i2.61
- Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). Breast cancer in Iran: an epidemiological review. Breast J, 13, 383-91. https://doi.org/10.1111/j.1524-4741.2007.00446.x
- Orel SG (1999). Differentiating Benign from Malignant Enhancing Lesions Identified at MR Imaging of the Breast: Are Time-Signal Intensity Curves an Accurate Predictor? 1. Radiol, 211, 5-7. https://doi.org/10.1148/radiology.211.1.r99ap395
- Roebuck JR, Cecil KM, Schnall MD, et al (1998). Human breast lesions: characterization with proton MR spectroscopy. Radiol, 209, 269-75. https://doi.org/10.1148/radiology.209.1.9769842
- Sardanelli F, Fausto A, Di Leo G, et al (2009). In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy. AmJ Roentgenol, 192, 1608-17. https://doi.org/10.2214/AJR.07.3521
- Sharifian A, Pourhoseingholi MA, Emadedin M, et al (2015). Burden of Breast Cancer in Iranian Women is Increasing. Asian Pac J Cancer Prev, 16, 5049-52. https://doi.org/10.7314/APJCP.2015.16.12.5049
- Stanwell P, Gluch L, Clark D, et al (2005). Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T. Eur Radiol, 15, 1037-43. https://doi.org/10.1007/s00330-004-2475-1
- Tan J, Xu L, Yao W, et al (2015). In vivo post-contrast 1H-MRS evaluation of malignant and benign breast lesions: a metaanalysis. Tumor Biol, 36, 345-52. https://doi.org/10.1007/s13277-014-2635-0
- Yeung DKW, Cheung HS, Tse GMK (2001). Human Breast Lesions: Characterization with Contrast-enhanced in Vivo Proton MR Spectroscopyac"Initial Results 1. Radiol, 220, 40-6. https://doi.org/10.1148/radiology.220.1.r01jl0240